T1	Participants 15 36	children with autism:
T2	Participants 200 221	children with autism.
T3	Participants 322 342	children with autism
T4	Participants 548 719	40 consecutive children with autism, whose ages ranged from 2 to 9 years, who were receiving either risperidone or placebo given orally at a dose of 1 mg/day for 6 months.
T5	Participants 922 942	40 children enrolled
T6	Participants 1821 1841	children with autism
